一种新型人TNFα对人肝癌裸鼠移植瘤的抗瘤作用

用人肝癌Ｂｅｌ７４０２瘤株建立了人肝癌裸鼠移植瘤模型，探讨新型重组人ＴＮＦａ对这种移植瘤的抗瘤作用，结果表明，ｒｈＴＦａＤ１１ａ和原型重组人ＴＮＦａ的抑瘤率在３０％左右时，后者后用的活性产闰数是前者的２倍；两者用量相同时，前者的抑产经比后者提高２３个百分     

HCMV感染动物胃肠组织损伤实验研究

目的 探讨HCMV感染是否引起大鼠和家兔胃肠组织损伤。方法 将人巨细胞病毒(Human Cyto—megalovirus，HCMV)AD168毒株静脉接种大鼠和新西兰兔，大鼠90d、兔30d后，检查动物胃、肠组织的病理变化，用免疫组化方法和原位杂交方法检查组织中的病毒抗原和DNA片段。结果 接种病毒之部分动物出现食量减少、粘液性大便，胃粘膜组织可见淋巴细胞浸润，肠粘膜变性坏死，甚至有穿孔灶；在粘膜细胞中查到病毒抗原或DNA片段。结论 HCMV感染可以侵犯动物胃肠组织并引起该组织病理损伤。     

格拉斯哥评分的纯数学意义及临床评估价值

总结１０２２例颅脑外伤进行格拉斯哥评分的实践实验，从纯数学意义上评价了评分在临床上的应用价值。指出格拉斯哥评分各参数之间只有１５种组合最常见且有临床价值。数学分析表明运动反应最有决定性意义；同时指出格拉斯可评分对患者预后判断有重要评估价值。评分的不足之处在于不能反映瞳孔改变和脑干症状。     

Quantitative relationship between pupillary reflex feature and its diopter in retinoscopy

ＱｕａｎｔｉｔａｔｉｖｅｒｅｌａｔｉｏｎｓｈｉｐｂｅｔｗｅｅｎｐｕｐｉｌｌａｒｙｒｅｆｌｅｘｆｅａｔｕｒｅａｎｄｉｔｓｄｉｏｐｔｅｒｉｎｒｅｔｉｎｏｓｃｏｐｙＸｕＳｈａｎｇ（徐上）；ＪｉＳｈａｎｇｎｉａｎ（计尚年）（ＤｅｐａｒｔｍｅｎｔｏｆＯｐｈｔｈ...     

~(60)Co-γ射线照射后HeLa细胞存活曲线和数学模式

本文研究了~(60)Co-γ射线照射后HeLa细胞的存活曲线,比较了两种数学模式拟合的结果.拟合优度以对误差加权的残差平方和(Q)作为统计指标进行评价.结果表明模式的拟合度较模式为优.     

热休克反应对大鼠油酸肺保护作用的机制研究

未研究发现，经热休克处理的大鼠注油酸后，肺组织损伤明显减轻，Ｗｅｓｔｅｒｎ印迹分析显示热休克使大鼠肺组织中ＨＳＰ７０含量明显增多；Ｎｏｒｔｈｅｒｎ印迹分析证实此乃由于ＨＳＰ７０ｍＲＮＡ转录增加所致。说明热休克处理使肺组织ＨＳＰ７０基因表达增强；提示热休克反应对大鼠油酸肺的保护作用与肺组织细胞中ＨＳＰ７０基因表达增强及与ＨＳＰ７０增多有关。     

A model for estimating the potential costs and savings of osteoporosis prevention strategies

A model was developed which estimates the costs of osteoporosis risk evaluation and treatment, and the resulting savings in terms of reduced fracture frequency, for the adult female population of the United States. In the absence of treatment, the model predicts 1.44 million fractures will occur annually from non-violent causes. Treatment of all women beginning at age 50 with an agent that slows bone loss by 50% would reduce the number of these fractures by 0.59 million. Selective treatment of the 47% of women at the greatest fracture risk would reduce the number of fractures by 0.45 million, but would only cost 47% as much as treating all women. Additional data are required before the model can be used to evaluate specific treatment regimens. However, it appears that selective treatment of those at highest risk would yield the greatest benefit to cost ratio, if only benefits related to reduced fracture frequency are considered.     

When should bone density measurements be repeated?

We calculated how long to wait before repeating bone mineral density (BMD) measurements to reassess fracture risk. Correlation results from serial measurements of 495 postmenopausal Japanese-American women were used to estimate 95% confidence intervals (CI) for future BMD. After 7 years of follow-up, BMD correlations with the initial measurement ranged between 0.81 and 0.94, depending on age group and measurement site. In this analysis, the period between measurements was defined as the time required for the lower 95% CI to fall below the BMD value corresponding to doubling of fracture risk. Progressive bone loss causes fracture risk to double after 10 years, on average. However, the 95% CIs indicate that a second BMD measurement will detect risk doubling after only 2 or 3 years for some women. For untreated, early postmenopausal women, the period between measurements was approximately 2–5 years for the radius and 4–6 years for the calcaneus, depending on the initial BMD level. The period was approximately 1 year longer for women age 60 and older. Treatments that halve the bone loss rate would increase the period by 1–3 years. In the absence of a second measurement of BMD, the CI will continue to expand with time, corresponding to a wider range in risk between individuals, and a greater proportion of women will be at increased fracture risk. Obtaining a second BMD measurement pinpoints the patient's status within the precision of the measurement. We conclude that repeated BMD measurements will provide a more accurate estimate of fracture risk than a single, baseline measurement.